| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |